Company Filing History:
1 out of 3 
1 out of 1 
1 out of 4 Years Active: 2017
Title: Kamil Dabrowski: Innovator in Bacteriophage Therapeutics
Introduction
Kamil Dabrowski is a notable inventor based in Sulejowek, Poland. He has made significant contributions to the field of bacteriophage therapy, particularly in evaluating the therapeutic efficacy of these preparations against pathogenic bacteria. His innovative approach utilizes a nematode in the assessment process, which has the potential to enhance treatment options for infections in both humans and animals.
Latest Patents
Kamil Dabrowski holds a patent for a method of evaluating the therapeutic efficacy of bacteriophages. This patent represents a novel use of a nematode in the evaluation of bacteriophage preparations, which are crucial in treating infections caused by harmful bacteria.
Career Highlights
Throughout his career, Kamil has worked with esteemed institutions such as the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Kamil has collaborated with notable colleagues, including Malgorzata Lobocka and Aleksandra Glowacka. These partnerships have further enriched his research and development efforts in the field of bacteriophage therapy.
Conclusion
Kamil Dabrowski's innovative work in bacteriophage therapeutics highlights his commitment to advancing medical science. His contributions are paving the way for new treatment methodologies that could significantly impact the fight against bacterial infections.